Arenavirus Nucleoprotein Targets Interferon Regulatory Factor-Activating Kinase IKKε
暂无分享,去创建一个
S. Kunz | J. C. de la Torre | L. Martínez-Sobrido | Christelle Pythoud | W. W. S. I. Rodrigo | G. Pasqual | S. Rothenberger | W. Rodrigo
[1] S. Kunz,et al. Arenavirus Nucleoproteins Prevent Activation of Nuclear Factor Kappa B , 2012, Journal of Virology.
[2] R. Myers,et al. IκB kinase ε (IKKε) regulates the balance between type I and type II interferon responses , 2011, Proceedings of the National Academy of Sciences.
[3] J. C. de la Torre,et al. The C-Terminal Region of Lymphocytic Choriomeningitis Virus Nucleoprotein Contains Distinct and Segregable Functional Domains Involved in NP-Z Interaction and Counteraction of the Type I Interferon Response , 2011, Journal of Virology.
[4] Zhijian J. Chen,et al. Role of the Clathrin Terminal Domain in Regulating Coated Pit Dynamics Revealed by Small Molecule Inhibition , 2011, Cell.
[5] S. Becker,et al. Tacaribe Virus but Not Junin Virus Infection Induces Cytokine Release from Primary Human Monocytes and Macrophages , 2011, PLoS neglected tropical diseases.
[6] Erica Ollmann Saphire,et al. Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3′ to 5′ exonuclease activity essential for immune suppression , 2011, Proceedings of the National Academy of Sciences.
[7] D. Garcin,et al. Short Double-stranded RNAs with an Overhanging 5′ ppp-Nucleotide, as Found in Arenavirus Genomes, Act as RIG-I Decoys* , 2010, The Journal of Biological Chemistry.
[8] K. Conzelmann,et al. Genetic Dissection of Interferon-Antagonistic Functions of Rabies Virus Phosphoprotein: Inhibition of Interferon Regulatory Factor 3 Activation Is Important for Pathogenicity , 2010, Journal of Virology.
[9] H. Ly,et al. Cap binding and immune evasion revealed by Lassa nucleoprotein structure , 2010, Nature.
[10] P. Borrow,et al. Inhibition of the Type I Interferon Antiviral Response During Arenavirus Infection , 2010, Viruses.
[11] E. Kurt-Jones,et al. Induction and Inhibition of Type I Interferon Responses by Distinct Components of Lymphocytic Choriomeningitis Virus , 2010, Journal of Virology.
[12] D. Garcin,et al. Unpaired 5′ ppp-Nucleotides, as Found in Arenavirus Double-stranded RNA Panhandles, Are Not Recognized by RIG-I* , 2010, The Journal of Biological Chemistry.
[13] J. C. D. L. Torre,et al. Molecular and cell biology of the prototypic arenavirus LCMV: implications for understanding and combating hemorrhagic fever arenaviruses. , 2009 .
[14] J. C. de la Torre. Molecular and Cell Biology of the Prototypic Arenavirus LCMV: Implications for Understanding and Combating Hemorrhagic Fever Arenaviruses , 2009, Annals of the New York Academy of Sciences.
[15] A. García-Sastre,et al. Identification of Amino Acid Residues Critical for the Anti-Interferon Activity of the Nucleoprotein of the Prototypic Arenavirus Lymphocytic Choriomeningitis Virus , 2009, Journal of Virology.
[16] W. Hahn,et al. Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation. , 2009, Molecular cell.
[17] C. Basler,et al. Ebola Virus Protein VP35 Impairs the Function of Interferon Regulatory Factor-Activating Kinases IKKε and TBK-1 , 2009, Journal of Virology.
[18] C. Horvath,et al. Select Paramyxoviral V Proteins Inhibit IRF3 Activation by Acting as Alternative Substrates for Inhibitor of κB Kinase ϵ (IKKe)/TBK1* , 2008, Journal of Biological Chemistry.
[19] J. Tschopp,et al. TRADD protein is an essential component of the RIG-like helicase antiviral pathway. , 2008, Immunity.
[20] Arnold Martin,et al. Processing of Genome 5′ Termini as a Strategy of Negative-Strand RNA Viruses to Avoid RIG-I-Dependent Interferon Induction , 2008, PloS one.
[21] J. Hiscott. Convergence of the NF-kappaB and IRF pathways in the regulation of the innate antiviral response. , 2007, Cytokine & growth factor reviews.
[22] A. García-Sastre,et al. Differential Inhibition of Type I Interferon Induction by Arenavirus Nucleoproteins , 2007, Journal of Virology.
[23] Paul J. Hertzog,et al. Type I Interferon Receptors: Biochemistry and Biological Functions* , 2007, Journal of Biological Chemistry.
[24] D. Levy,et al. JAK-STAT Signaling: From Interferons to Cytokines* , 2007, Journal of Biological Chemistry.
[25] Eric S. Lander,et al. Integrative Genomic Approaches Identify IKBKE as a Breast Cancer Oncogene , 2007, Cell.
[26] G. Kochs,et al. Multiple Anti-Interferon Actions of the Influenza A Virus NS1 Protein , 2007, Journal of Virology.
[27] T. Maniatis,et al. Multiple Functions of the IKK-Related Kinase IKKε in Interferon-Mediated Antiviral Immunity , 2007, Science.
[28] M. Wiznerowicz,et al. Suppression of the Sendai Virus M Protein through a Novel Short Interfering RNA Approach Inhibits Viral Particle Production but Does Not Affect Viral RNA Synthesis , 2006, Journal of Virology.
[29] A. García-Sastre,et al. Inhibition of the Type I Interferon Response by the Nucleoprotein of the Prototypic Arenavirus Lymphocytic Choriomeningitis Virus , 2006, Journal of Virology.
[30] Sean F. Eddy,et al. Inducible IκB Kinase/IκB Kinase ε Expression Is Induced by CK2 and Promotes Aberrant Nuclear Factor-κB Activation in Breast Cancer Cells , 2005 .
[31] Ralf Bartenschlager,et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus , 2005, Nature.
[32] Osamu Takeuchi,et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction , 2005, Nature Immunology.
[33] Z. Zhai,et al. VISA Is an Adapter Protein Required for Virus-Triggered IFN-β Signaling , 2005 .
[34] Zhijian J. Chen,et al. Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3 , 2005, Cell.
[35] S. Finke,et al. Identification of the Rabies Virus Alpha/Beta Interferon Antagonist: Phosphoprotein P Interferes with Phosphorylation of Interferon Regulatory Factor 3 , 2005, Journal of Virology.
[36] Peter B Jahrling,et al. Exotic emerging viral diseases: progress and challenges , 2004, Nature Medicine.
[37] G. Cheng,et al. Differential Requirement for TANK-binding Kinase-1 in Type I Interferon Responses to Toll-like Receptor Activation and Viral Infection , 2004, The Journal of experimental medicine.
[38] Osamu Takeuchi,et al. The Roles of Two IκB Kinase-related Kinases in Lipopolysaccharide and Double Stranded RNA Signaling and Viral Infection , 2004, The Journal of experimental medicine.
[39] M. Georges-Courbot,et al. Lassa Virus Infection of Human Dendritic Cells and Macrophages Is Productive but Fails to Activate Cells1 , 2004, The Journal of Immunology.
[40] T. Maniatis,et al. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[41] Shizuo Akira,et al. Toll/IL-1 Receptor Domain-Containing Adaptor Inducing IFN-β (TRIF) Associates with TNF Receptor-Associated Factor 6 and TANK-Binding Kinase 1, and Activates Two Distinct Transcription Factors, NF-κB and IFN-Regulatory Factor-3, in the Toll-Like Receptor Signaling 1 , 2003, The Journal of Immunology.
[42] B. Pulendran,et al. Cutting Edge: Impairment of Dendritic Cells and Adaptive Immunity by Ebola and Lassa Viruses1 , 2003, The Journal of Immunology.
[43] W. Garten,et al. Endoproteolytic Processing of the Lymphocytic Choriomeningitis Virus Glycoprotein by the Subtilase SKI-1/S1P , 2003, Journal of Virology.
[44] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[45] N. Seidah,et al. The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[46] K. Campbell,et al. Molecular analysis of the interaction of LCMV with its cellular receptor α-dystroglycan , 2001, The Journal of cell biology.
[47] C. Samuel,et al. Antiviral Actions of Interferons , 2001, Clinical Microbiology Reviews.
[48] T. Maniatis,et al. IKKε Is Part of a Novel PMA-Inducible IκB Kinase Complex , 2000 .
[49] S. Akira,et al. IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases. , 1999, International immunology.
[50] R. Rueckert. Picornaviridae: The viruses and their replication , 1996 .
[51] M. Saron,et al. Chronic production of interferon in carrier mice congenitally infected with lymphocytic choriomeningitis virus. , 1982, Virology.
[52] M. Buchmeier,et al. Monoclonal antibodies to lymphocytic choriomeningitis and pichinde viruses: generation, characterization, and cross-reactivity with other arenaviruses. , 1981, Virology.
[53] S. Goodbourn,et al. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. , 2008, The Journal of general virology.
[54] T. Maniatis,et al. Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. , 2007, Science.
[55] D. Seldin,et al. Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells. , 2005, Cancer research.
[56] Zhijian J. Chen,et al. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. , 2005, Cell.
[57] Z. Zhai,et al. VISA is an adapter protein required for virus-triggered IFN-beta signaling. , 2005, Molecular cell.
[58] M. Oldstone. Biology and pathogenesis of lymphocytic choriomeningitis virus infection. , 2002, Current topics in microbiology and immunology.
[59] C. Peters. Human infection with arenaviruses in the Americas. , 2002, Current topics in microbiology and immunology.
[60] M. Buchmeier,et al. Arenaviridae: The viruses and their replication , 2001 .
[61] T. Maniatis,et al. IKKepsilon is part of a novel PMA-inducible IkappaB kinase complex. , 2000, Molecular cell.
[62] A. Anusz. [Lassa fever]. , 1981, Pielegniarka i polozna.